Patient engagement, the new paradigm of clinical research (made possible by digital technology)

Dec 6, 2019 | Articles

In recent years, patient engagement in clinical trials has emerged as an increasingly important aspect for the success of clinical trials. The European Medicines Agency (EMA) has long been committed to greater patient’s involvement and has expressed the benefits of...

Exom Group appoints Luca Visani, MD as Chief Medical Officer Oncology

Dec 2, 2019 | Company News

Milan, Italy – Exom Group, the Human & Digital CRO, announced and welcomed Luca Visani, MD, as new Chief Medical Officer Oncology (CMOO). Luca Visani, MD, who is a Radiation Oncology specialist, brings sound experience in Clinical Trials in Oncology, and will be...

Advanced Analytics is revolutionizing clinical trials: the experience of Exom Group, the first European digital CRO, to implement such an innovative approach.

Nov 13, 2019 | Articles, Case Stydy, Company News

Despite the opportunities offered by the digital revolution of recent decades, the organizational and management model of clinical trials has not changed significantly. The reason for this is because the industry is notoriously conservative, risk-averse, and highly...

SCRIP Awards Ceremony

Oct 16, 2019 | Uncategorized

Meet our CEO Dr. Luigi Visani and our Director Clinical Operations at the SCRIP Award Ceremony in London. When: December 4, 2019 Location: Hilton on Park Lane, London   Exom is joining the event as an Award Finalist in the Category of “Best Technological...

Exom named Finalist of the SCRIP AWARDS 2019 in “Best Technological Development in Clinical Trials”

Sep 13, 2019 | Articles, Company News, Genius Suite

Milan, Italy / Ulm, Germany | Exom Group, the Global Digital Full-Service CRO, proudly announces that its digital platform Genius ROSA has been nominated Finalist of the Scrip Awards 2019 edition for the category Best Technological Development in Clinical Trials....